194 related articles for article (PubMed ID: 35595309)
41. The Long Pentraxin PTX3 as a Humoral Innate Immunity Functional Player and Biomarker of Infections and Sepsis.
Porte R; Davoudian S; Asgari F; Parente R; Mantovani A; Garlanda C; Bottazzi B
Front Immunol; 2019; 10():794. PubMed ID: 31031772
[TBL] [Abstract][Full Text] [Related]
42. Pentraxin 3 Modulates the Inflammatory Response in Human Dental Pulp Cells.
Kim Y; Park JS; Park HJ; Kim MK; Kim YI; Bae SK; Kim HJ; Jeong CH; Bae MK
J Endod; 2018 Dec; 44(12):1826-1831. PubMed ID: 30477668
[TBL] [Abstract][Full Text] [Related]
43. Pentraxin 3 inhibits fibroblast growth factor 2-dependent activation of smooth muscle cells in vitro and neointima formation in vivo.
Camozzi M; Zacchigna S; Rusnati M; Coltrini D; Ramirez-Correa G; Bottazzi B; Mantovani A; Giacca M; Presta M
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1837-42. PubMed ID: 16020751
[TBL] [Abstract][Full Text] [Related]
44. Pentraxin-3-mediated complement activation in a swine model of renal ischemia/reperfusion injury.
Divella C; Stasi A; Franzin R; Rossini M; Pontrelli P; Sallustio F; Netti GS; Ranieri E; Lacitignola L; Staffieri F; Crovace AM; Lucarelli G; Ditonno P; Battaglia M; Daha MR; van der Pol P; van Kooten C; Grandaliano G; Gesualdo L; Stallone G; Castellano G
Aging (Albany NY); 2021 Apr; 13(8):10920-10933. PubMed ID: 33875620
[TBL] [Abstract][Full Text] [Related]
45. Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.
Witasp A; Rydén M; Carrero JJ; Qureshi AR; Nordfors L; Näslund E; Hammarqvist F; Arefin S; Kublickiene K; Stenvinkel P
PLoS One; 2013; 8(5):e63493. PubMed ID: 23658833
[TBL] [Abstract][Full Text] [Related]
46. Stimulation of the B-cell receptor activates the JAK2/STAT3 signaling pathway in chronic lymphocytic leukemia cells.
Rozovski U; Wu JY; Harris DM; Liu Z; Li P; Hazan-Halevy I; Ferrajoli A; Burger JA; O'Brien S; Jain N; Verstovsek S; Wierda WG; Keating MJ; Estrov Z
Blood; 2014 Jun; 123(24):3797-802. PubMed ID: 24778152
[TBL] [Abstract][Full Text] [Related]
47. The long pentraxin PTX3 as a key component of humoral innate immunity and a candidate diagnostic for inflammatory diseases.
Jaillon S; Bonavita E; Gentile S; Rubino M; Laface I; Garlanda C; Mantovani A
Int Arch Allergy Immunol; 2014; 165(3):165-78. PubMed ID: 25531094
[TBL] [Abstract][Full Text] [Related]
48. Tumor endothelial cells express high pentraxin 3 levels.
Hida K; Maishi N; Kawamoto T; Akiyama K; Ohga N; Hida Y; Yamada K; Hojo T; Kikuchi H; Sato M; Torii C; Shinohara N; Shindoh M
Pathol Int; 2016 Dec; 66(12):687-694. PubMed ID: 27862647
[TBL] [Abstract][Full Text] [Related]
49. ALK4-SMAD2/3-SMAD4 signaling mediates the activin A-induced suppression of PTX3 in human granulosa-lutein cells.
Liu C; Chang HM; Yi Y; Fang Y; Zhao F; Leung PCK; Yang X
Mol Cell Endocrinol; 2019 Aug; 493():110485. PubMed ID: 31185247
[TBL] [Abstract][Full Text] [Related]
50. IL-6, IL-10, c-Jun and STAT3 expression in B-CLL.
Antosz H; Wojciechowska K; Sajewicz J; Choroszyńska D; Marzec-Kotarska B; Osiak M; Pająk N; Tomczak W; Jargiełło-Baszak M; Baszak J
Blood Cells Mol Dis; 2015 Mar; 54(3):258-65. PubMed ID: 25477266
[TBL] [Abstract][Full Text] [Related]
51. Elevated plasma level of Pentraxin 3 is associated with emphysema and mortality in smokers.
Zhang Y; Tedrow J; Nouraie M; Li X; Chandra D; Bon J; Kass DJ; Fuhrman CR; Leader JK; Duncan SR; Kaminski N; Sciurba FC
Thorax; 2021 Apr; 76(4):335-342. PubMed ID: 33479043
[TBL] [Abstract][Full Text] [Related]
52. Pentraxin 3 expression in lungs and neutrophils of calves.
Townsend M; Singh B
Vet Immunol Immunopathol; 2021 Jun; 236():110251. PubMed ID: 33901710
[TBL] [Abstract][Full Text] [Related]
53. Viability and stress protection of chronic lymphoid leukemia cells involves overactivation of mitochondrial phosphoSTAT3Ser727.
Capron C; Jondeau K; Casetti L; Jalbert V; Costa C; Verhoeyen E; Massé JM; Coppo P; Béné MC; Bourdoncle P; Cramer-Bordé E; Dusanter-Fourt I
Cell Death Dis; 2014 Oct; 5(10):e1451. PubMed ID: 25299776
[TBL] [Abstract][Full Text] [Related]
54. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer.
Bonavita E; Gentile S; Rubino M; Maina V; Papait R; Kunderfranco P; Greco C; Feruglio F; Molgora M; Laface I; Tartari S; Doni A; Pasqualini F; Barbati E; Basso G; Galdiero MR; Nebuloni M; Roncalli M; Colombo P; Laghi L; Lambris JD; Jaillon S; Garlanda C; Mantovani A
Cell; 2015 Feb; 160(4):700-714. PubMed ID: 25679762
[TBL] [Abstract][Full Text] [Related]
55. M-ficolin interacts with the long pentraxin PTX3: a novel case of cross-talk between soluble pattern-recognition molecules.
Gout E; Moriscot C; Doni A; Dumestre-Pérard C; Lacroix M; Pérard J; Schoehn G; Mantovani A; Arlaud GJ; Thielens NM
J Immunol; 2011 May; 186(10):5815-22. PubMed ID: 21490156
[TBL] [Abstract][Full Text] [Related]
56. Pentraxin 3, long expression in mononuclear cells of patients with acute coronary syndrome: Correlation with C-reactive protein and matrix metalloproteinase-9 levels.
Ma R; Zhang W; Wang T; He X; Huang Z; Zhu J; Yao Z
J Int Med Res; 2014 Jun; 42(3):677-83. PubMed ID: 24709882
[TBL] [Abstract][Full Text] [Related]
57. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.
Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X
Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517
[TBL] [Abstract][Full Text] [Related]
58. Knockdown of Pentraxin 3 suppresses tumorigenicity and metastasis of human cervical cancer cells.
Ying TH; Lee CH; Chiou HL; Yang SF; Lin CL; Hung CH; Tsai JP; Hsieh YH
Sci Rep; 2016 Jul; 6():29385. PubMed ID: 27377307
[TBL] [Abstract][Full Text] [Related]
59. The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology.
Boudny M; Trbusek M
Klin Onkol; 2020; 33(1):32-38. PubMed ID: 32075387
[TBL] [Abstract][Full Text] [Related]
60. Particulate matter-mediated release of long pentraxin 3 (PTX3) and vascular endothelial growth factor (VEGF) in vitro: Limited importance of endotoxin and organic content.
Herseth JI; Volden V; Bolling AK
J Toxicol Environ Health A; 2017; 80(2):105-119. PubMed ID: 28071984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
